Attapulgite, Polycarbophil Excluded From OTC Antidiarrheal Final Monograph
This article was originally published in The Tan Sheet
Executive Summary
Activated attapulgite is reclassified from proposed Category I status to nonmonograph in the 1OTC Antidiarrheal Drug Products final monograph, published in the April 17 Federal Register
You may also be interested in...
Bismuth Subsalicylate Inclusion In Overindulgence TFM Urged By P&G
An FDA request for more information on a 13-year-old Procter & Gamble submission on bismuth subsalicylate could indicate the agency's interest in moving towards completion of the overindulgence monograph
Bismuth Subsalicylate Inclusion In Overindulgence TFM Urged By P&G
An FDA request for more information on a 13-year-old Procter & Gamble submission on bismuth subsalicylate could indicate the agency's interest in moving towards completion of the overindulgence monograph
Bismuth Subsalicylate Inclusion In Overindulgence TFM Urged By P&G
An FDA request for more information on a 13-year-old Procter & Gamble submission on bismuth subsalicylate could indicate the agency's interest in moving towards completion of the overindulgence monograph